D'ANDREA, MARCO MARIA
 Distribuzione geografica
Continente #
NA - Nord America 9.697
AS - Asia 4.216
EU - Europa 3.147
Continente sconosciuto - Info sul continente non disponibili 587
SA - Sud America 539
AF - Africa 287
OC - Oceania 91
Totale 18.564
Nazione #
US - Stati Uniti d'America 9.387
SG - Singapore 1.359
IT - Italia 1.148
CN - Cina 618
BR - Brasile 406
HK - Hong Kong 399
RU - Federazione Russa 393
IE - Irlanda 319
DE - Germania 283
GB - Regno Unito 245
IN - India 219
VN - Vietnam 203
JP - Giappone 200
IR - Iran 175
BD - Bangladesh 170
CA - Canada 163
PK - Pakistan 158
SA - Arabia Saudita 150
FR - Francia 130
KR - Corea 113
NL - Olanda 94
FI - Finlandia 86
AU - Australia 80
TR - Turchia 80
ES - Italia 73
MX - Messico 64
EG - Egitto 60
IQ - Iraq 60
ZA - Sudafrica 58
PL - Polonia 57
PH - Filippine 56
ID - Indonesia 47
NG - Nigeria 44
AR - Argentina 39
CH - Svizzera 39
CZ - Repubblica Ceca 38
AT - Austria 36
JO - Giordania 36
SE - Svezia 36
MY - Malesia 35
TH - Thailandia 35
ET - Etiopia 33
BE - Belgio 27
CR - Costa Rica 27
UA - Ucraina 27
TW - Taiwan 25
CL - Cile 23
DK - Danimarca 23
EC - Ecuador 22
NP - Nepal 22
CO - Colombia 21
GH - Ghana 15
JM - Giamaica 15
MA - Marocco 14
AE - Emirati Arabi Uniti 13
RO - Romania 13
IL - Israele 12
GR - Grecia 11
HN - Honduras 11
HU - Ungheria 11
PE - Perù 11
DZ - Algeria 10
KE - Kenya 10
NO - Norvegia 10
TN - Tunisia 10
EE - Estonia 9
GT - Guatemala 8
LT - Lituania 8
RS - Serbia 8
NZ - Nuova Zelanda 7
PT - Portogallo 7
SN - Senegal 7
VE - Venezuela 7
AL - Albania 6
GE - Georgia 6
PY - Paraguay 6
SV - El Salvador 6
UZ - Uzbekistan 6
CI - Costa d'Avorio 5
ER - Eritrea 4
LY - Libia 4
NI - Nicaragua 4
FJ - Figi 3
MO - Macao, regione amministrativa speciale della Cina 3
MW - Malawi 3
QA - Qatar 3
TT - Trinidad e Tobago 3
UY - Uruguay 3
BB - Barbados 2
BG - Bulgaria 2
CY - Cipro 2
EU - Europa 2
KG - Kirghizistan 2
LB - Libano 2
PR - Porto Rico 2
SI - Slovenia 2
UG - Uganda 2
XK - ???statistics.table.value.countryCode.XK??? 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AO - Angola 1
Totale 17.955
Città #
Wilmington 919
San Jose 902
Ashburn 858
Singapore 794
Houston 764
Fairfield 491
Chandler 471
Woodbridge 379
Council Bluffs 335
Hong Kong 308
Dublin 282
Beijing 258
Rome 226
Medford 203
Seattle 197
New York 186
Cambridge 165
The Dalles 149
Los Angeles 142
Jeddah 132
Ann Arbor 123
Tokyo 122
Santa Clara 113
Lawrence 92
Milan 91
Lauterbourg 73
São Paulo 70
Hanoi 67
Helsinki 66
Ho Chi Minh City 64
Buffalo 59
Dallas 55
Moscow 53
San Diego 53
Frankfurt am Main 50
Munich 50
London 47
Hamburg 41
Philadelphia 39
Seoul 39
Toronto 38
Cairo 37
Atlanta 36
Chicago 36
Amman 35
Lahore 34
Redwood City 34
Brooklyn 33
Warsaw 33
Florence 32
Orem 32
Denver 29
Prague 29
Central 28
Chennai 28
Jakarta 28
Minneapolis 28
Montreal 28
North Bergen 28
Nuremberg 27
Tehran 27
Berlin 25
Phoenix 25
Naples 23
Chuo 22
Columbus 22
Redondo Beach 22
Calgary 21
Delhi 21
Melbourne 21
Menlo Park 21
Mumbai 20
New Delhi 20
Sydney 20
Istanbul 19
Bologna 18
Amsterdam 17
Birmingham 17
Johannesburg 17
Madrid 17
Manchester 17
San Francisco 17
Santiago 17
Washington 17
Boston 16
Des Moines 16
Miami 16
San José 16
Shanghai 16
Turin 16
Vienna 16
Bangkok 15
Durban 15
Karachi 15
Norwalk 15
Addis Ababa 14
Copenhagen 14
Falls Church 14
Knoxville 14
Las Vegas 14
Totale 10.886
Nome #
Fighting multi-drug resistant Klebsiella pneumoniae by using lytic phages 720
Characterization of four novel bacteriophages targeting multi-drug resistant Klebsiella pneumoniae strains of sequence type 147 and 307 684
Exploiting phages–bacteria co-evolution to overcome phage resistance and to ease the selection of new phage particles 603
φbO1E, a newly discovered lytic bacteriophage targeting carbapenemase-producing Klebsiella pneumoniae of the pandemic Clonal Group 258 clade II lineage 496
First report of multi-drug resistant, VEB-6 producing Proteus mirabilis isolates from Italy 489
Draft genome sequence of the agarase-producing Sphingomonas sp. MCT13 408
Genetic linkage of optrA and cfr, integrated into an unconventional circularisable structure, in Enterococcus faecium 380
Chromosomal Integration of blaKPC-2 in Proteus mirabilis Clinical Isolates 357
Characterization of vB_Kpn_F48, a Newly Discovered Lytic Bacteriophage for Klebsiella pneumoniae of Sequence Type 101 342
MCT13: a newly discovered agarase-producing Sphingomonas sp. Isolated from freshwaters 342
Sphingomonas turrisvirgatae a new agar-degrading Sphingomonas species 342
Tn6349: a novel cfr- and poxtA-carrying transposon of enterococcal origin in a linezolid-resistant MRSA 318
Isolation and characterization of lytic bacteriophages targeting major multi-drug resistant high-risk clones of carbapenemase-producing Klebsiella pneumoniae 315
Isolation and characterisation of vB_Kpn_F48, a novel bacteriophage for Klebsiella pneumoniae 312
The lytic bacteriophage vB_EfaH_EF1TV, a new member of the Herelleviridae family, disrupts biofilm produced by Enterococcus faecalis clinical strains 299
Preclinical study of a combined host- and pathogen directed approach based on bioactive liposomes and bacteriophages against Mycobacterium abscessus infection 253
Molecular epidemiology of KPC-producing Klebsiella pneumoniae from invasive infections in Italy: Increasing diversity with predominance of the ST512 clade II sublineage 230
The urgent need for novel antimicrobial agents and strategies to fight antibiotic resistance 228
Characterization of vb_stus_mmda13, a newly discovered bacteriophage infecting the agar-degrading species sphingomonas turrisvirgatae 210
Sphingomonas turrisvirgatae sp. nov., an agar-degrading species isolated from freshwater. 206
Abundance of Colistin-Resistant, OXA-23- and ArmA-Producing Acinetobacter baumannii Belonging to International Clone 2 in Greece 203
SELECTION AND CHARACTERISATION OF PHAGES ABLE TO DEGRADE BIOFILM PRODUCED BY CLINICAL ISOLATES OF E. FAECALIS 202
The changing epidemiology of carbapenemase-producing Klebsiella pneumoniae in Italy: toward polyclonal evolution with emergence of high-risk lineages 194
Italian nationwide survey on pseudomonas aeruginosa from invasive infections: Activity of ceftolozane/tazobactam and comparators, and molecular epidemiology of carbapenemase producers 193
Evidence of another anthropic impact on iguana delicatissima from the lesser Antilles: the presence of antibiotic resistant enterobacteria 183
Assessment of the Phoenix™ automated system and EUCAST breakpoints for antimicrobial susceptibility testing against isolates expressing clinically relevant resistance mechanisms 181
CTX-M-type β-lactamases: A successful story of antibiotic resistance 177
Characterization of a multiresistance plasmid carrying the optra and Cfr resistance genes from an enterococcus faecium clinical isolate 175
Characterization of poxtA, a novel phenicol-oxazolidinone-tetracycline resistance gene from an MRSA of clinical origin 169
Characterization of pABVA01, a plasmid encoding the OXA-24 carbapenemase from Italian isolates of Acinetobacter baumannii 160
Combined host- and pathogen-directed therapy for the control of mycobacterium abscessus infection 156
Phage-resistance in Klebsiella pneumoniae clinical isolates may correlate to augmented clearance by phagocytes 155
Fighting MDR-Klebsiella pneumoniae infections by a combined host- and pathogen-directed therapeutic approach 154
Characterization of Tn6349, a novel mosaic transposon carrying poxtA, cfr and other resistance determinants, inserted in the chromosome of an ST5-MRSA-II strain of clinical origin 146
Phage-resistance mechanism in KPC-producing Klebsiella pneumoniae of the clonal group 258 clade II lineage 146
Application of bacteriophages for human health: an old approach against contemporary “bad bugs” 141
A dirty job: dishwasher wastewater reuse and upcycle through an ad hoc engineered microbial consortium 138
Characterization of bacteriophages with lytic activity for major clones of KPC-producing Klebsiella pneumoniae. 135
Liposomes Loaded With Phosphatidylinositol 5-Phosphate Improve the Antimicrobial Response to Pseudomonas aeruginosa in Impaired Macrophages From Cystic Fibrosis Patients and Limit Airway Inflammatory Response 135
Phage Resistance Is Associated with Decreased Virulence in KPC-Producing Klebsiella pneumoniae of the Clonal Group 258 Clade II Lineage 134
Spread of multidrug-resistant Proteus mirabilis isolates producing an AmpC-type β-lactamase: epidemiology and clinical management 133
DNABII targeting antibodies as vaccines against biofilm diseases 133
CMY-16, a novel acquired AmpC-type β-lactamase of the CMY/LAT lineage in multifocal monophyletic isolates of Proteus mirabilis from northern Italy 132
Characterization of a novel putative Xer-dependent integrative mobile element carrying the blaNMC-A carbapenemase gene, inserted into the chromosome of members of the Enterobacter cloacae complex 130
The seagrass holobiont: what we know and what we still need to disclose for its possible use as an ecological indicator 129
Phosphatidylserine liposomes reduce inflammatory response, mycobacterial viability and HIV replication in coinfected human macrophages 129
Determination of the capsular polysaccharide structure of the Klebsiella pneumoniae ST512 representative strain KPB-1 and assignments of the glycosyltransferases functions 127
Genomic Epidemiology of Carbapenem- and Colistin-Resistant Klebsiella pneumoniae Isolates From Serbia: Predominance of ST101 Strains Carrying a Novel OXA-48 Plasmid 126
Phosphatidylcholine Liposomes Down-Modulate CD4 Expression Reducing HIV Entry in Human Type-1 Macrophages 126
Genomic epidemiology of carbapenem- and colistin-resistant Acinetobacter baumannii from Greece 124
Bioactive liposomes for the control of Mycobacterium abscessus infection. 123
Acquired AmpC type beta-lactamases: An emerging problem in Italian long-term care and rehabilitation facilities 122
Lytic bacteriophages against KPC-KP and their efficacy in a preclinical model. 119
Carbapenem-resistant Klebsiella pneumoniae: the role of plasmids in emergence, dissemination, and evolution of a major clinical challenge 118
Uncovering the Fungal Community Composition of Alive and Dead Posidonia oceanica Matte 117
Molecular and physiological characterization of a new lytic bacteriophage against KPC-positive Klebsiella pneumoniae. 117
Home Sweet Home: Setting the Best Thriving Conditions for the Ad Hoc Engineered Microbial Consortium in the Zero Mile System 116
Multiple CTX-M-type extended-spectrum β-lactamases in nosocomial isolates of Enterobacteriaceae from a hospital in Northern Italy 116
Emergence in Italy of Klebsiella pneumoniae sequence type 258 producing KPC-3 carbapenemase 115
In vivo emergence of colistin resistance in Klebsiella pneumoniae producing KPC-type carbapenemases mediated by insertional inactivation of the PhoQ/PhoP mgrB regulator 115
Characterization of four novel bacteriophages targeting multi-drug resistant Klebsiella pneumoniae strains of sequence type 147 and 307 113
A phototrophic/heterotrophic microbial consortium able to reuse and upcycle dishwasher wastewater in Zero-Mile food production 113
Cross-infection of solid organ transplant recipients by a multidrug-resistant Klebsiella pneumoniae isolate producing the OXA-48 carbapenemase, likely derived from a multiorgan donor 112
Structure of the capsular polysaccharide of the KPC-2-producing Klebsiella pneumoniae strain KK207-2 and assignment of the glycosyltransferases functions 112
Epidemiological characterization and distribution of carbapenem-resistant Acinetobacter baumannii clinical isolates in Italy 112
In vivo evolution to Colistin resistance by PmrB sensor kinase mutation in KPC-producing Klebsiella pneumoniae is associated with low-dosage colistin treatment 109
Colistin resistance caused by inactivation of the MgrB regulator is not associated with decreased virulence of sequence type 258 KPC carbapenemase-producing Klebsiella pneumoniae 109
Effects of selective digestive decontamination (SDD) on the gut resistome 109
Draft genome sequence of the first hypermucoviscous Klebsiella quasipneumoniae subsp. quasipneumoniae isolate from a bloodstream infection 107
MgrB inactivation is a common mechanism of colistin resistance in KPC-producing klebsiella pneumoniae of clinical origin 106
Phosphaditylserine liposomes as a possible candidate for the therapeutic management of Mycobacterium abscessus infection in CF patients 105
pHTβ-promoted mobilization of non-conjugative resistance plasmids from Enterococcus faecium to Enterococcus faecalis 104
Complete genome sequence of the first KPC-type carbapenemase-positive Proteus mirabilis strain from a bloodstream infection 104
A Helping Hand: Fungi, as Well as Bacteria, Support Ecophysiological Descriptors to Depict the Posidonia oceanica Conservation Status 103
Microbial consortia in wastewater treatment and up-cycling. 103
Large oligoclonal outbreak due to klebsiella pneumoniae ST14 and ST26 producing the FOX-7 AmpC β-lactamase in a neonatal intensive care unit 103
The spread of CTX-M-type extended-spectrum β-lactamases 102
Persistent carriage and infection by multidrug-resistant Escherichia coli ST405 producing NDM-1 carbapenemase: Report on the first Italian cases 101
First case of bacteremic liver abscess caused by an ST260-related (ST1861), hypervirulent Klebsiella pneumoniae 100
Molecular and Kinetic Characterization of MOX-9, a Plasmid-Mediated Enzyme Representative of a Novel Sublineage of MOX-Type Class C β-Lactamases 97
Diversity of capsular polysaccharide gene clusters in Kpc-producing Klebsiella pneumoniae clinical isolates of sequence type 258 involved in the italian epidemic 96
Mining microbial metatranscriptomes for expression of antibiotic resistance genes under natural conditions 96
Draft genome sequence of Proteus mirabilis NO-051/ 03, representative of a multidrug-resistant clone spreading in Europe and expressing the CMY-16 AmpC-type β-lactamase 95
Management of meningitis caused by multi drug-resistant Acinetobacter baumannii: Clinical, microbiological and pharmacokinetic results in a patient treated with colistin methanesulfonate 94
Infections caused by carbapenem-resistant Klebsiella pneumoniae with hypermucoviscous phenotype: A case report and literature review 93
Isolation of Klebsiella pneumoniae strains with altered susceptibility to carbapenems not carbapenemase mediated 93
Phosphatidylserine liposomes induce a phagosome acidification-dependent and ROS-mediated intracellular killing of Mycobacterium abscessus in human macrophages 92
Plasmid-mediated or chromosomally mediated colistin resistance in Klebsiella pneumoniae? 92
Diversity and Composition of Posidonia oceanica-Associated Bacterial and Fungal Communities: Effect of Boat-Induced Mechanical Stress in the Villefranche-sur-Mer Bay (France) 91
Linezolid-resistant cfr-positive MRSA, Italy 90
Galleria mellonella for assessing the efficacy of monoclonal antibodies against Staphylococcus aureus 89
Evolution and spread of a multidrug-resistant Proteus mirabilis clone with chromosomal AmpC-type cephalosporinases in Europe 89
Italian nationwide survey on Pseudomonas aeruginosa from invasive infections: activity of ceftolozane-tazobactam and comparators, and molecular epidemiology of carbapenemase producers. 87
Differences in Inflammatory Response Induced by Two Representatives of Clades of the Pandemic ST258 Klebsiella pneumoniae Clonal Lineage Producing KPC-Type Carbapenemases 86
Phosphatidylinositol 5-Phosphate-Loaded Apoptotic Body-Like Liposomes for Mycobacterium abscessus Infection Management in Patients With Cystic Fibrosis 84
DNA microarray for detection of macrolide resistance genes 83
The interplay of diagnostic and antimicrobial stewardship for the management of septic patients: The Tuscan model 80
OXA-372, a novel carbapenem-hydrolysing class D β-lactamase from a Citrobacter freundii isolated from a hospital wastewater plant 79
Nasopharingeal bacterial and fungal colonization in HIV-positive versus HIV-negative adults 78
NDM-1 encoding plasmids in multiple Enterobacteriaceae from a pediatric patient. 78
Totale 17.167
Categoria #
all - tutte 70.884
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 70.884


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022922 0 0 0 10 62 71 77 145 74 63 96 324
2022/20231.332 141 118 97 140 85 330 123 66 113 18 55 46
2023/20241.802 89 35 49 249 190 392 221 184 91 93 98 111
2024/20253.191 169 436 295 203 154 212 373 190 374 253 271 261
2025/20265.383 395 222 532 378 340 212 693 642 549 493 665 262
2026/20272.126 285 256 1.029 556 0 0 0 0 0 0 0 0
Totale 18.564